H.R.6711 - Medical Supply Transparency and Delivery Act116th Congress (2019-2020)
|Sponsor:||Rep. Crow, Jason [D-CO-6] (Introduced 05/05/2020)|
|Committees:||House - Financial Services; Transportation and Infrastructure; Armed Services; Energy and Commerce|
|Latest Action:||House - 05/05/2020 Referred to the Committee on Financial Services, and in addition to the Committees on Transportation and Infrastructure, Armed Services, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.6711 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (05/05/2020)
Medical Supply Transparency and Delivery Act
This bill provides for the procurement and distribution of equipment and supplies needed to combat COVID-19 (i.e., coronavirus disease 2019).
The bill sets forth responsibilities for the National Response Coordination Center (NRCC) of the Federal Emergency Management Agency, including that the NRCC must (1) direct the national production and distribution of critical medical equipment and supplies; (2) communicate with states, local governments, and Native American tribes regarding the availability and delivery schedule of equipment and supplies; and (3) make specified information publicly available.
The Department of Defense may detail members of the Armed Forces on active duty or civilian employees to support the NRCC.
The President, using authorities provided under the Defense Production Act of 1950, must establish a fair and reasonable price for and procure needed equipment and supplies.
The Government Accountability Office must annually submit a report to Congress assessing the Strategic National Stockpile.
The Council of the Inspectors General on Integrity and Efficiency shall designate an inspector general to oversee this bill's implementation.